Dechert represents sovereign issuers and financial sponsors which include investment banks and asset managers in a range of debt offerings and private placements. Practitioners demonstrate strong expertise in cross-border offerings, and such expertise also exists in the context of transactions ranging from joint ventures to bankruptcies. Thomas Friedmann in Boston, who is a common point of contact for alternative asset managers, Stephen Leitzell in Philadelphia and Harry Pangas in Washington DC are at the helm. Clay Douglas, also in Washington DC, is another key name to note for his knowledge of capital raising.
Legal 500 Editorial commentary
Accolades
Client satisfaction: Lawyer & team quality
Client satisfaction: Sector knowledge
Key clients
- Aquestive Therapeutics
- B&G Foods
- Bain Capital Specialty Finance
- BC Partners
- BioAtla
- Blackstone
- Business Development Company of America
- Diffusion Therapeutics
- EaglePoint Credit Company
- FS Investment Corporation
- Golub Capital BDC, Inc.
- Griffon Corporation
Work highlights
Represented Crown Holdings in connection with multiple debt offerings and its offering of €500 million aggregate principal amount of 3.750% senior unsecured notes due 2031 issued at par by its subsidiary Crown European Holdings S.A.
Represented HPS Corporate Lending Fund in its private placement notes offering in an aggregate principal amount of $750 million of its 5.450% notes due 2028 and in an aggregate principal amount of $500 million of its 5.950% notes due 2032.
Represented HPS Corporate Lending Fund in connection with its offering of $600 millionin aggregate principal amount of its 4.900% notes due 2028 and $500 million in aggregate principal amount of its 5.450% notes due 2030.
Practice head
Thomas Friedmann; Stephen Leitzell; Harry Pangas
Other key lawyers
Matthew Carter; Clay Douglas